News | January 10, 2025
Windlas Biotech’s new injectable facility receives GMP certification
The certification marks a new chapter in Windlas Biotech’s growth trajectory,
The certification marks a new chapter in Windlas Biotech’s growth trajectory,
The project is set to attract significant manufacturing investments of approximately Rs. 10,500 crore and is also projected to create around 1 lakh direct and indirect jobs
Data from IDSP does not indicate any unusual rise in ILI/SARI cases anywhere in the country
NutrifyGenie AI, a leading AI-driven platform, was integral in designing scientifically differentiated formulations for a multinational client
ICMR will continue to track trends in HMPV circulation throughout the year
2.92 acre facility will combine tradition and innovation, offering new opportunities for holistic healing, specialized clinics, and skill development to be constructed at a cost of around Rs. 185 crore
He has 29+ years’ comprehensive experience in world-class Formulations and API (for US and EU requirements) mainly related to injectables
The facility is equipped with state-of-the-art technology to produce high-quality lyophilized (freeze-dried) products
Anthem’s business comprises of CRDMO services and the manufacture and sale of Specialty Ingredients
Thyrocare becomes first national diagnostic chain with 100% of its labs with NABL accreditation
Subscribe To Our Newsletter & Stay Updated
